Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial

American Journal of Medicine

Volumn 124, Issue 5, 2011, Pages 434-443

  Ribichini, Flavio ^a,f   Tomai, Fabrizio ^b   De Luca, Giuseppe ^c   Boccuzzi, Giacomo ^d   Presbitero, Patrizia ^e   Pesarini, Gabriele ^a   Ferrero, Valeria ^a   Ghini, Anna S ^b   Abukaresh, Ramadan ^a   Aurigemma, Cristina ^b   De Luca, Leonardo ^b   Zavalloni, Dennis ^e   Soregaroli, Daniela ^e   Marino, Paolo ^c   Garbo, Roberto ^d   Zanolla, Luisa ^a   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b EUROPEAN HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

Author keywords

Coronary artery disease; Prednisone; Randomized clinical trial; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; PACLITAXEL; PREDNISONE; PROTON PUMP INHIBITOR; RAPAMYCIN; THIAZIDE DIURETIC AGENT; TICLOPIDINE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MIDDLE AGED; PREDNISONE; RESEARCH DESIGN; STENTS; TREATMENT OUTCOME;

EID: 79955603100     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.11.027     Document Type: Article

References (34)

1. F. Versaci, A. Gaspardone, and F. Tomai Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study) J Am Coll Cardiol 40 2002 1935 1942 (Pubitemid 35425363)
2. F. Ribichini, F. Tomai, and V. Ferrero Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease The IMPRESS-2/MVD study EuroIntervention 2 2005 173 180
3. V. Ferrero, F. Tomai, and F. Versaci Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels EuroIntervention 5 2009 250 254
4. A. Farb, G. Sangiorgi, and A. Carter Pathology of acute and chronic coronary stenting in humans Circulation 99 1999 44 52 (Pubitemid 29035956)
5. A. Farb, D.K. Weber, and F.D. Kolodgie Morphological predictors of restenosis after coronary stenting in humans Circulation 105 2002 2974 2980 (Pubitemid 34693829)
6. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids New mechanisms for old drugs N Engl J Med 353 2005 1711 1723
7. V. Ferrero, F. Ribichini, and G. Pesarini Therapeutic potential of glucocorticoids in the prevention of restenosis after coronary angioplasty Drugs 67 2007 1243 1255 (Pubitemid 46879092)
8. F. Ribichini, F. Tomai, and G. De Luca A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES)study design and rationale J Cardiovasc Med 10 2009 192 199
9. G.W. Stone, B.D. Rutherford, and D.R. McConahay A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty Cathet Cardiovasc Diagn 18 1989 227 231 (Pubitemid 20088550)
10. C.J. Pepine, J.W. Hirshfeld, and R.G. Macdonald A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty Circulation 81 1990 1753 1761 (Pubitemid 20183823)
11. C.W. Lee, J. Chae, and H. Lim Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation Am Heart J 138 1999 60 63 (Pubitemid 29331122)
12. F. Ribichini, F. Tomai, L. Paloscia DESIRE investigators Steroid-eluting stents in patients with acute coronary syndromes The DESIRE: Dexamethasone Eluting Stent Italian REgistry Heart 93 2007 598 600 (Pubitemid 46707113)
13. V. Ferrero, F. Ribichini, and A. Rognoni Comparison of efficacy and safety of lowered-dose to higher-dose oral prednisone after percutaneous coronary intervention The IMPRESS-LD Study Am J Cardiol 99 2007 1082 1086 (Pubitemid 46560466)
14. J.A. Lindenfeld, G.G. Miller, and S.F. Shakar Drug therapy in the heart transplant recipient Part II: immunosuppressive drugs Circulation 110 2004 3858 3865 (Pubitemid 40023985)
15. F. Ribichini, V. Ferrero, and A. Rognoni Percutaneous treatment of coronary bifurcations: lesion preparation before provisional stenting and subsequent immunosuppression with oral prednisone The IMPRESS-Y study J Interv Cardiol 20 2007 114 121 (Pubitemid 46457443)
16. A.E. Rodriguez, J.F. Granada, M. Rodriguez-Alemparte ORAR II Investigators Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study J Am Coll Cardiol 47 2006 1522 1529
17. R. Waksman, A.E. Ajani, and A.D. Pichard Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study J Am Coll Cardiol 44 2004 1386 1392 (Pubitemid 39303938)
18. J. Hausleiter, A. Kastrati, J. Mehilli OSIRIS Investigators Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial Circulation 110 2004 790 795 (Pubitemid 39096005)
19. F. Ribichini, M. Joner, and V. Ferrero Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis J Am Coll Cardiol 50 2007 176 185 (Pubitemid 47002181)
20. F. Ribichini, V. Ferrero, and M. Feola Neutropenia in patients treated with thienopyridines and high-dose oral prednisone after percutaneous coronary interventions J Interven Cardiol 20 2007 209 213 (Pubitemid 46808879)
21. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780 (Pubitemid 34586912)
22. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary arteries N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
23. J. Schofer, M. Schluter, and A.H. Gershilck Sirolimus-eluting stents for the treatment of patients with long atherosclerotic lesions in small coronary arteries: a double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099 (Pubitemid 37222332)
24. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
25. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
26. M.C. Morice, A. Colombo, and B. Meier Sirolimus vs paclitaxel-eluting stents in de novo coronary artery lesions The reality trial: a randomized controlled trial JAMA 295 2006 895 904
27. C. Kaiser, H.P. Brunner-La Rocca, and P.T. Buser Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitts Trial (BASKET) Lancet 366 2005 921 929 (Pubitemid 41265666)
28. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents J Am Coll Cardiol 48 2007 2584 2591
29. J. Pache, A. Kastrati, and J. Mehilli Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 2003 1283 1288 (Pubitemid 36438988)
30. A. Kastrati, A. Schmig, and S. Elezi Predictive factors of restenosis after coronary stent placement J Am Coll Cardiol 30 1997 1428 1436 (Pubitemid 27486458)
31. C. Bauters, E. Hubert, and A. Prat Predictors of restenosis after coronary stent implantation J Am Coll Cardiol 31 1998 1291 1298 (Pubitemid 28219119)
32. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
33. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
34. G. Pesarini, A. Amoroso, and V. Ferrero Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans Atherosclerosis 211 2010 242 248